Egypt to produce up to 80 million Sinovac vaccine doses annually

CAIRO: Egypt has agreed with China’s Sinovac Biotech Ltd. to manufacture its COVID-19 vaccine domestically, and could produce up to 80 million doses a year, the health ministry said on Thursday.
The agreement could provide a major boost to vaccination efforts in Egypt, which has a population of 100 million and has thus far received just 1.5 million doses.
Egypt’s cabinet and presidency approved a joint manufacturing agreement to make the vaccines that will be distributed in Egypt and to other African countries, Zayed said.